Comparison of DNMT1 Inhibitors by Methylome Profiling Identifies Unique Signature of 5-aza-2′Deoxycytidine

References

• Klutstein M , NejmanD , GreenfieldR , CedarH . DNA methylation in cancer and aging . Cancer Res.76 ( 12 ), 3446 – 3450 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Weisenberger DJ . Characterizing DNA methylation alterations from The Cancer Genome Atlas . J. Clin. Invest.124 ( 1 ), 17 – 23 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence . Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia (TA218) ( 2011 ).
   Google Scholar
• Smith ZD , MeissnerA . DNA methylation: roles in mammalian development . Nat. Rev. Genet.14 , 204 – 220 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Klimasauskas S , KumarS , RobertsRJ , ChengX . Hhal methyltransferase flips its target base out of the DNA helix . Cell76 ( 2 ), 357 – 369 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Bestor TH . Cloning of a mammalian DNA methyltransferase . Gene74 ( 1 ), 9 – 12 ( 1988 ).
   PubMed Web of Science ®Google Scholar
• Fahy J , JeltschA , ArimondoPB . DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies . Expert Opin. Ther. Pat.22 ( 12 ), 1427 – 1442 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhou L , ChengX , ConnollyBA , DickmanMJ , HurdPJ , HornbyDP . Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases . J. Mol. Biol.321 ( 4 ), 591 – 599 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Jones PA , TaylorSM . Cellular differentiation, cytidine analogs and DNA methylation . Cell20 ( 1 ), 85 – 93 ( 1980 ).
   PubMed Web of Science ®Google Scholar
• Kaminskas E , FarrellAT , WangYC , SridharaR , PazdurR . FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension . Oncologist10 ( 3 ), 176 – 182 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov: NCT02472145 ( 2017 ). https://clinicaltrials.gov/ct2/show/NCT02472145 .
   Google Scholar
• Fenaux P , MuftiGJ , Hellstrom-LindbergEet al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, Phase III study . Lancet Oncol.10 ( 3 ), 223 – 232 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lubbert M , SuciuS , HagemeijerAet al. Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized Phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group . Ann. Hematol.95 ( 2 ), 191 – 199 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Yun S , VinceletteND , AbrahamI , RobertsonKD , Fernandez-ZapicoME , PatnaikMM . Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials . Clin. Epigenet.8 , 68 – 77 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Cheishvili D , BoureauL , SzyfM . DNA demethylation and invasive cancer: implications for therapeutics . Br. J. Pharmacol.172 ( 11 ), 2705 – 2715 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Juttermann R , LiE , JaenischR . Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation . Proc. Natl Acad. Sci. USA91 ( 25 ), 11797 – 11801 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Okano M , BellDW , HaberDA , LiE . DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development . Cell99 ( 3 ), 247 – 257 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Ghoshal K , DattaJ , MajumderSet al. 5-aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal . Mol. Cell. Biol.25 ( 11 ), 4727 – 4727 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Lynch CA , TyckoB , BestorTH , WalshCP . Reactivation of a silenced H19 gene in human rhabdomyosarcoma by demethylation of DNA but not by histone hyperacetylation . Mol. Cancer1 , 2 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Irwin R , ThakurA , O’NeillKM , WalshCP . 5-Hydroxymethylation marks a class of neuronal gene regulated by intragenic methylcytosine levels . Genomics104 ( 5 ), 383 – 392 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Rutledge CE , ThakurA , O’NeillKMet al. Ontogeny, conservation and functional significance of maternally inherited DNA methylation at two classes of non-imprinted genes . Development141 ( 6 ), 1313 – 1323 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Santini V , KantarjianHM , IssaJP . Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications . Ann. Intern. Med.134 , 573 – 586 ( 2011 ).
   Google Scholar
• Herman JG , UmarA , PolyakKet al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma . Proc. Natl Acad. Sci. USA95 ( 12 ), 6870 – 6875 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Raj K , MuftiGJ . Azacytidine (Vidaza(R)) in the treatment of myelodysplastic syndromes . Ther. Clin. Risk Manag.2 ( 4 ), 377 – 388 ( 2006 ).
   PubMedGoogle Scholar
• Pandiyan K , YouJS , YangXet al. Functional DNA demethylation is accompanied by chromatin accessibility . Nucleic Acids Res.41 ( 7 ), 3973 – 3985 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Traina F , VisconteV , ElsonPet al. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms . Leukemia28 ( 1 ), 78 – 87 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Bibikova M , BarnesB , TsanCet al. High density DNA methylation array with single CpG site resolution . Genomics98 ( 4 ), 288 – 295 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Assenov Y , MullerF , LutsikP , WalterJ , LengauerT , BockC . Comprehensive analysis of DNA methylation data with RnBeads . Nat. Methods11 ( 11 ), 1138 – 1140 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Huang da W , ShermanBT , LempickiRA . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources . Nat. Protoc.4 ( 1 ), 44 – 57 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Thomas PD , CampbellMJ , KejariwalAet al. PANTHER: a library of protein families and subfamilies indexed by function . Genome Res.13 ( 9 ), 2129 – 2141 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Afgan E , BakerD , van den BeekMet al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update . Nucleic Acids Res.44 ( W1 ), W3 – W10 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Kent WJ , SugnetCW , FureyTSet al. The human genome browser at UCSC . Genome Res.12 ( 6 ), 996 – 1006 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Diesch J , ZwickA , GarzA , PalauA , BuschbeckM , GötzKS . A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers . Clin. Epigenetics8 , 71 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Yang X , HanH , De CarvalhoDD , LayFD , JonesPA , LiangG . Gene body methylation can alter gene expression and is a therapeutic target in cancer . Cancer Cell26 ( 4 ), 577 – 590 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Smallwood S , KelseyG . De novo DNA methylation: a germ cell perspective . Trends Genet.28 ( 1 ), 33 – 42 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Shukla S , KavakE , GregoryMet al. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing . Nature479 ( 7371 ), 74 – 79 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yoshida K , SanadaM , ShiraishiYet al. Frequent pathway mutations of splicing machinery in myelodysplasia . Nature478 ( 7367 ), 64 – 69 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kulis M , HeathS , BibikovaMet al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia . Nat. Genet.44 ( 11 ), 1236 – 1242 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Jones PA , BaylinSB . The fundamental role of epigenetic events in cancer . Nat. Rev. Genet.3 ( 6 ), 415 – 428 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Kuendgen A , GattermannN . Valproic acid for the treatment of myeloid malignancies . Cancer110 ( 5 ), 943 – 954 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Jones PL , VeenstraGJ , WadePAet al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription . Nat. Genet.19 ( 2 ), 187 – 191 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Garcia-Manero G , KantarjianHM , Sanchez-GonzalezBet al. Phase I/II study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia . Blood108 ( 10 ), 3271 – 3279 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Fredly H , GjertsenBT , BruserudO . Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents . Clin. Epigenetics5 ( 1 ), 12 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lemaire M , MomparlerLF , FarinhaNJ , BernsteinM , MomparlerRL . Enhancement of antineoplastic action of 5-aza-2′-deoxycytidine by phenylbutyrate on L1210 leukemic cells . Leuk. Lymphoma45 ( 1 ), 147 – 154 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Gore SD , BaylinS , SugarEet al. Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms . Cancer Res.66 ( 12 ), 6361 – 6369 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Plass C , OakesC , BlumW , MarcucciG . Epigenetics in acute myeloid leukemia . Semin. Oncol.35 ( 4 ), 378 – 387 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Feigin ME . Harnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesis . FEBS J.280 ( 19 ), 4729 – 4738 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Rabin M , BirnbaumD , YoungD , BirchmeierC , WiglerM , RuddleFH . Human ros1 and mas1 oncogenes located in regions of chromosome 6 associated with tumor-specific rearrangements . Oncogene Res.1 ( 2 ), 169 – 178 ( 1987 ).
   PubMedGoogle Scholar
• Wen P , KongR , LiuJet al. USP33, a new player in lung cancer, mediates Slit–Robo signaling . Protein Cell5 ( 9 ), 704 – 713 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wang L , ZhangH , HasimAet al. Partition-defective 3 (PARD3) regulates proliferation, apoptosis, migration, and invasion in esophageal squamous cell carcinoma cells . Med. Sci. Monit.23 , 2382 – 2390 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Wozniak RJ , KlimeckiWT , LauSS , FeinsteinY , FutscherBW . 5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation . Oncogene26 ( 1 ), 77 – 90 ( 2007 ).
   PubMed Web of Science ®Google Scholar